2nd Quarter - Report

ARENTFOX SCHIFF LLP for TRANSPARENCY-RX CORP.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices S. 1339 (Pharmacy Benefit Manager Reform Act), all provisions

LobbyistCovered position, as disclosed
PHILIP ENGLISH —
DANIEL SJOSTEDT —
OLIVER SPURGEON III —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1339 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.